New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device
Tempus AI, Inc. - Class A (TEM)
Company Research
Source: Business Wire
New decision establishes reimbursement for the clinical use of Tempus ECG-AF, reducing the financial burden of using AI to improve early detection of atrial fibrillation CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the impact of a new decision by the Centers for Medicare and Medicaid Services (CMS) that will allow reimbursement for assessments of cardiac dysfunction using the Tempus ECG-AF algorithm. ECG-AF is one of just a few FDA-authorized medical technologies in the country to be impacted by the new CMS decision, and this milestone allows Tempus to more broadly support clinicians in identifying patients at increased risk of atrial fibrillation/flutter (AF).Per the CMS policy to allow payment for certain Software as a Service (SaaS) devices in the Hospital Outpatient setting, CMS has assigned associated procedure codes for assessments with assistive algorit
Show less
Read more
Impact Snapshot
Event Time:
TEM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEM alerts
High impacting Tempus AI, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
TEM
News
- Tempus Now an In-Network Provider for Blue Cross Blue Shield Illinois, Blue Shield California, and Avalon Healthcare SolutionsBusiness Wire
- New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device [Yahoo! Finance]Yahoo! Finance
- Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & DiagnosisGlobeNewswire
- Tempus AI, Inc. (NASDAQ: TEM) had its price target raised by analysts at Bank of America Co. from $52.00 to $54.00. They now have a "neutral" rating on the stock.MarketBeat
- Tempus AI, Inc. (NASDAQ: TEM) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $60.00 price target on the stock.MarketBeat
TEM
Earnings
- 11/4/24 - Miss
TEM
Sec Filings
- 12/20/24 - Form 4
- 12/18/24 - Form 4
- 12/18/24 - Form 4
- TEM's page on the SEC website